YoVDO

MRD in Solid Tumor and Hematological Indications: Today and Tomorrow

Offered By: Labroots via YouTube

Tags

Oncology Courses Hematology Courses Cancer Treatment Courses Next-Generation Sequencing Courses Solid Tumors Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore the current and future applications of Measurable Residual Disease (MRD) testing in solid tumor and hematological indications through this informative webinar presented by Dr. Bob Holt and Prof. Maria Teresa Voso. Delve into the concept of MRD, which refers to the presence of minute tumor cell populations persisting after treatment. Discover how MRD testing is utilized clinically to identify disease relapse and guide patient treatment strategies. Examine the traditional use of MRD in hematological indications and learn about its expanding role in solid tumor indications, facilitated by advancements in next-generation sequencing (NGS) and circulating tumor DNA (ctDNA) based testing. Gain insights into the evolving landscape of MRD applications and their potential impact on cancer management and patient outcomes.

Syllabus

MRD in solid tumor and hematological indications: today and tomorrow


Taught by

Labroots

Related Courses

Practical tips to improve Asian American participation in cancer clinical trials
Stanford University via Coursera
Thoracic Oncology
University of Michigan via Coursera
Medical Genomics 101
Davidson College via edX
Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique
Medical Cannabis for Pain Control
Technion - Israel Institute of Technology via Coursera